🔎 Trials Near Me

Home › Idiopathic Hypersomnia › Florida

Idiopathic Hypersomnia clinical trials in Florida

7 studies for Idiopathic Hypersomnia are looking for participants at sites in Florida.

Cities in Florida

A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

  • Takeda Site 11, Brandon
  • Takeda Site 7, Miami
  • Takeda Site 18, Winter Park
RecruitingPhase 2/3
Ages 18 to 71 · All sexes · Updated Sep 18, 2026 · NCT07646678

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

  • PharmDev Research Institute, LLC, Miami
  • Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC), Winter Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

  • Alkermes Investigational Site, Brandon
  • Alkermes Investigational Site, Miami
  • Alkermes Investigational Site, Winter Park
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

  • Takeda Site 19, Brandon
  • Takeda Site 14, Winter Park
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 15, 2026 · NCT06812078

Low Sodium Oxybate in Patients With Idiopathic Hypersomnia

  • Mayo Clinic Florida, Jacksonville
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated May 12, 2026 · NCT05837091

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Brandon, Florida, Brandon
  • Miami, Florida, Miami
  • Miami, Florida, Miami
  • and 2 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 27, 2026 · NCT06752668

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

  • Miami, Florida, Miami
  • Orlando, Florida, Orlando
  • Winter Park, FL, Winter Park
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.